Bio Essence (BIOE) Net Margin (2020 - 2026)

Bio Essence (BIOE) recorded quarterly Net Margin of 41.03% in Q1 2026, down 41.01% quarter-over-quarter from 69.56% in Q4 2025, and up 96830.0% on a YoY basis from N/an in Q1 2025.

Bio Essence (BIOE) Net Margin (2020 - 2026) Analysis & Trends

Bio Essence's Net Margin history runs 7 years deep, the most recent figure standing at 41.03% for Q1 2026.

  • In Q1 2026, Net Margin rose 96830.0% year-over-year to 41.03%; the TTM figure through Mar 2026 stood at 55.02% (up 14938.0% YoY), while the FY2025 annual figure was 47.23%, up 8453.0% from the prior year.
  • Net Margin was 41.03% for Q1 2026 at Bio Essence, down from 69.56% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 245.51% in Q1 2024 to a low of 927.27% in Q1 2025.
  • Historically, Net Margin has averaged 71.3% across 5 years, with a median of 41.03% in 2026.
  • The sharpest annual moves came in 2025 and 2026: Net Margin tumbled 117278 bps in 2025, then jumped 96830 bps in 2026.
  • A 5-year view of Net Margin shows it stood at 129.16% in 2022, then slumped by 136 bps to 304.3% in 2023, then jumped by 71 bps to 89.71% in 2024, then surged by 178 bps to 69.56% in 2025, then sank by 41 bps to 41.03% in 2026.
  • The last three Net Margin figures came in at 41.03% (Q1 2026), 69.56% (Q4 2025), and 9.5% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 9.19%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 26.57%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 35.18%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 2.94%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 24.30%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 4.16%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -168.42%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.15%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 31.38%
10 Bio Essence - - 319,353.00 41.03%

Historic Data

Download Data
DateValue
Mar 31, 2026 41.03%
Dec 31, 2025 69.56%
Sep 30, 2025 9.50%
Jun 30, 2025 23.10%
Mar 31, 2025 -927.27%
Sep 30, 2024 -89.71%
Mar 31, 2024 245.51%
Dec 31, 2023 -304.30%
Sep 30, 2023 -406.65%
Jun 30, 2023 109.61%
Mar 31, 2023 52.39%
Dec 31, 2022 -129.16%
Sep 30, 2022 103.74%
Jun 30, 2022 56.98%
Mar 31, 2022 76.08%
Dec 31, 2021 42.54%
Sep 30, 2021 80.64%
Jun 30, 2021 69.32%
Mar 31, 2021 -99.21%
Dec 31, 2020 -40.90%